J Fam Pract. 2023 Oct;72(8 Suppl):S1-S12. doi: 10.12788/jfp.0666.
Upon completion of this activity, participants will:Have increased knowledge regarding the Mechanistic differences between proton pump inhibitors (PPIs) and potassium-competitive acid blockers (PCABs) Evidence comparing PPIs with PCABs for the treatment of GERD and EE Have greater competence related to Selecting evidence-based treatments for EE.
完成此活动后,参与者将:
增加对质子泵抑制剂 (PPI) 和钾竞争酸阻滞剂 (PCAB) 之间的机制差异的了解;
比较 PPI 和 PCAB 治疗 GERD 和 EE 的证据;
提高与 EE 的循证治疗选择相关的能力。